Protocol summary

Study aim
The Effect of Levothyroxine on Cardiac Function in Children with Subclinical Hypothyroidism
Design
Clinical trial without control group; the sample size includes all of the eligibility criteria that 30-sample are predictable, phase 2 clinical trial.
Settings and conduct
This clinical trial study was performed will be selected by an inhomogeneous method in Children aged 4-12 years with subclinical hypothyroidism referring to Amirkola Children's Hospital Endocrinology Clinic.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Children aged 4-12 years with subclinical, Exclusion Criteria: Obese children, Children with high blood pressure, Children who already use levothyroxine, Children with congenital or acquired heart disease proven and under medical treatment, Children with liver or kidney disease, Children with high blood lipids, Children with diabetes, Children with infectious diseases.
Intervention groups
Children aged 4 to 12 years who referred to the endocrinology clinic were diagnosed with subclinical hypothyroidism. Treatment with 0.1 mg levothyroxine tablets starts with hormones with a dose of 4 micrograms per kilogram per day, which will be used by the patients in the early hours of fasting.
Main outcome variables
LVSD ، LVDD ، FS ، EF ، E/E' ،MPI

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20180228038900N3
Registration date: 2018-12-02, 1397/09/11
Registration timing: registered_while_recruiting

Last update: 2018-12-02, 1397/09/11
Update count: 0
Registration date
2018-12-02, 1397/09/11
Registrant information
Name
Morteza Alihanpour Aghamaleki
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 11 3234 6963
Email address
m.alijanpour@mubabol.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-10-14, 1397/07/22
Expected recruitment end date
2019-10-14, 1398/07/22
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The Effect of Levothyroxine on Cardiac Function in Children with Subclinical Hypothyroidism
Public title
The Effect of Levothyroxine on Cardiac Function in Children with Subclinical Hypothyroidism
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Diagnosis of subclinical hypothyroidism
Exclusion criteria:
Obese children Children with hypertension Children who already use levothyroxine Children with congenital or acquired heart disease proven and under medical treatment Children with liver or kidney disease Children with high blood lipids Children with diabetes Children with infectious diseases
Age
From 4 years old to 12 years old
Gender
Both
Phase
3
Groups that have been masked
No information
Sample size
Target sample size: 30
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Single
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Babol University of Medical Sciences
Street address
Vice- Chancellor for Research Technology Affairs, Babol University of Medical Sciences, Ganjafroz Street
City
Babol
Province
Mazandaran
Postal code
4717647745
Approval date
2018-10-14, 1397/07/22
Ethics committee reference number
IR.MUBABOL.HRI.REC.1397.153

Health conditions studied

1

Description of health condition studied
Hypothyroidism Subclinical
ICD-10 code
E01.2
ICD-10 code description
Iodine-deficiency-related (endemic) goitre, unspecified

Primary outcomes

1

Description
left ventricular end-systolic diameter
Timepoint
Before starting treatment
Method of measurement
Echocardiography

2

Description
left ventricular end-Dystolic diameter
Timepoint
Before starting treatment
Method of measurement
Echocardiography

3

Description
Fractional - Shortening
Timepoint
Before starting treatment
Method of measurement
Echocardiography

4

Description
Tissue Doppler echocardiography
Timepoint
Before starting treatment
Method of measurement
Echocardiography

5

Description
Ejection fraction
Timepoint
Before starting treatment
Method of measurement
Echocardiography

6

Description
Myocardial Perfusion Imaging
Timepoint
Before starting treatment
Method of measurement
Echocardiography

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: For patients, 0.1 mg levothyroxine tablets are prescribed by Iranian company Hormones with a dose of 4 micro/miligrams per day.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Amirkola Children’s Hospital
Full name of responsible person
Morteza Alijanpour Aghamaleki
Street address
Amirkola Children’s Hospital, Street No. 19
City
Babol
Province
Mazandaran
Postal code
4731741151
Phone
+98 11 3234 6963
Fax
+98 11 3234 6963
Email
m.alijanpour@yahoo.com
Web page address
http://amirkola.mubabol.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Babol University of Medical Sciences
Street address
Vice- Chancellor for Research Technology Affairs, Babol University of Medical Sciences, Ganjafroz Street
City
Babol
Province
Mazandaran
Postal code
4717647745
Phone
+98 11 3219 7667
Email
r.ghadimi@mubabol.ac.ir
Web page address
http://www.mubabol.ac.ir/
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Babol University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Morteza Alihanpour Aghamaleki
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
Amirkola Children’s Hospital, Street No. 19
City
Babol
Province
Mazandaran
Postal code
4731741151
Phone
+98 11 3234 6963
Email
m.alijanpour@mubabol.ac.ir
Web page address
http://amirkola.mubabol.ac.ir/

Person responsible for scientific inquiries

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Morteza Alijanpour Aghamaleki
Position
Associatant professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
Amirkola Children’s Hospital, Street No. 19
City
Babol
Province
Mazandaran
Postal code
4731741151
Phone
+98 11 3234 6963
Fax
+98 11 3234 6963
Email
m.alijanpour@mubabol.ac.ir
Web page address
http://amirkola.mubabol.ac.ir/

Person responsible for updating data

Contact
Name of organization / entity
Babol University of Medical Sciences
Full name of responsible person
Nasrin Bano Rupani
Position
Rezident
Latest degree
Medical doctor
Other areas of specialty/work
Pediatrics
Street address
Amirkola Children’s Hospital, Street No. 19
City
Babol
Province
Mazandaran
Postal code
4731741151
Phone
+98 11 3234 6963
Fax
+98 11 3234 6963
Email
rupani.nb17@gmail.com
Web page address
http://amirkola.mubabol.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
-
When the data will become available and for how long
-
To whom data/document is available
Public access
Under which criteria data/document could be used
-
From where data/document is obtainable
Dr. Morteza Alijanpour
What processes are involved for a request to access data/document
Email as soon as possible.
Comments
Loading...